Conference LibraryGated
Kelonia Therapeutics · KLN-1010 (per ASGCT 2025 abstracts)
Kelonia Therapeutics · in vivo cell therapy 公司 · KLN-1010 是主要 pipeline candidate(per OPORD-002 §2 P1 verify list · ASGCT 2025 abstracts)。 对 SunVax 的对标:in vivo cell engineering 大方向 · 具体 modality 待 verify。
- Type
- company
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- B
- category
- in_vivo_car_t_lentiviral
- status
- draft
- instance_tag
- sunvax-antibody-2025
- platform_tech
- in vivo cell therapy (modality TBD)
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.